Assignee
UNIV OREGON HEALTH & SCIENCE
US·245 granted patents·218 pending applications·1,555 citations·filing 1997–2025
Top patents by PatentIndex Score
463 records- 0197US11459558B2Methods for using transcription-dependent directed evolution of AAV capsidsUNIV OREGON HEALTH & SCIENCE·Filed 2021·Granted Oct 4, 2022·9 cites·20 claims
- 0296US11572637B2Methods of viral neutralizing antibody epitope mappingUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Feb 7, 2023·5 cites·2 claims
- 0396US10101329B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Oct 16, 2018·9 cites·46 claims
- 0496US9677088B2Adeno associated virus plasmids and vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jun 13, 2017·59 cites·15 claims
- 0595US12084653B2Methods for using transcription-dependent directed evolution of AAV capsidsUNIV OREGON HEALTH & SCIENCE·Filed 2023·Granted Sep 10, 2024·1 cites·12 claims
- 0695US12084654B2Methods for using transcription-dependent directed evolution of AAV capsidsUNIV OREGON HEALTH & SCIENCE·Filed 2023·Granted Sep 10, 2024·1 cites·12 claims
- 0795US9636399B2Anti-factor XI monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 2, 2017·15 cites·22 claims
- 0895US7289906B2Navigation system applications of sigma-point Kalman filters for nonlinear estimation and sensor fusionUNIV OREGON HEALTH & SCIENCE·Filed 2005·Granted Oct 30, 2007·102 cites·31 claims
- 0994US9125895B2Anti-factor XI monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Sep 8, 2015·19 cites·15 claims
- 1094US7265218B2Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH & SCIENCE·Filed 2004·Granted Sep 4, 2007·39 cites·1 claims
- 1193US11679082B2Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitorUNIV OREGON HEALTH & SCIENCE·Filed 2021·Granted Jun 20, 2023·6 cites·20 claims
- 1293US11224573B2Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitorUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Jan 18, 2022·10 cites·51 claims
- 1393US9783823B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Oct 10, 2017·14 cites·28 claims
- 1493US9701650B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jul 11, 2017·11 cites·8 claims
- 1593US9249427B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2012·Granted Feb 2, 2016·24 cites·24 claims
- 1693US8361707B2Methods for detecting a Mycobacterium tuberculosis infectionUNIV OREGON HEALTH & SCIENCE·Filed 2011·Granted Jan 29, 2013·10 cites·12 claims
- 1793US6436437B1Covalent polar lipid conjugates with neurologically active compounds for targetingUNIV OREGON HEALTH & SCIENCE·Filed 2000·Granted Aug 20, 2002·50 cites·12 claims
- 1892US12059500B2Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitorUNIV OREGON HEALTH & SCIENCE·Filed 2023·Granted Aug 13, 2024·3 cites·20 claims
- 1992US9982241B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 29, 2018·13 cites·54 claims
- 2092US9883866B2Clips and applicator for tissue closureUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Feb 6, 2018·60 cites·24 claims
- 2192US6815171B2Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH & SCIENCE·Filed 2001·Granted Nov 9, 2004·39 cites·14 claims
- 2291US10870616B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Dec 22, 2020·5 cites·25 claims
- 2391US10688164B2CMV vectors comprising microRNA recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jun 23, 2020·8 cites·23 claims
- 2491US10532099B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jan 14, 2020·8 cites·67 claims
- 2591US9637550B2Anti-fXI antibodies and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted May 2, 2017·14 cites·21 claims
- 2691US8940883B2Anti-fXI antibodies and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jan 27, 2015·15 cites·12 claims
- 2791US7192930B2Method and peptide for regulating cellular activityUNIV OREGON HEALTH & SCIENCE·Filed 2005·Granted Mar 20, 2007·14 cites·6 claims
- 2890US10316334B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jun 11, 2019·4 cites·23 claims
- 2990US9862972B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jan 9, 2018·10 cites·55 claims
- 3090US9541553B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jan 10, 2017·10 cites·36 claims
- 3190US7026157B1Bacterial hemoglobin receptor genesUNIV OREGON HEALTH & SCIENCE·Filed 2000·Granted Apr 11, 2006·32 cites·3 claims
- 3289US11510887B2Sobetirome in the treatment of myelination diseasesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Nov 29, 2022·3 cites·8 claims
- 3389US11325886B2Amide compounds, pharmaceutical compositions thereof, and methods of using the sameUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted May 10, 2022·5 cites·14 claims
- 3489US10544075B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jan 28, 2020·5 cites·22 claims
- 3589US8053181B2Methods for detecting a Mycobacterium tuberculosis infectionUNIV OREGON HEALTH & SCIENCE·Filed 2007·Granted Nov 8, 2011·10 cites·19 claims
- 3689US7132399B2Mammalian cell surface DNA receptorUNIV OREGON HEALTH & SCIENCE·Filed 2003·Granted Nov 7, 2006·27 cites·3 claims
- 3789US6414130B1HER-2 binding antagonistsUNIV OREGON HEALTH & SCIENCE·Filed 2000·Granted Jul 2, 2002·41 cites·7 claims
- 3888US11613517B2Amide prodrugs of small molecule nuclear receptor modulatorsUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Mar 28, 2023·4 cites·3 claims
- 3988US10392356B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Aug 27, 2019·8 cites·11 claims
- 4088US7842299B2Methods for producing an immune response to tuberculosisUNIV OREGON HEALTH & SCIENCE·Filed 2007·Granted Nov 30, 2010·8 cites·15 claims
- 4188US7592142B2Detection of gleevec resistanceUNIV OREGON HEALTH & SCIENCE·Filed 2008·Granted Sep 22, 2009·11 cites·25 claims
- 4288US7416873B2Detection of gleevec resistant mutationsUNIV OREGON HEALTH & SCIENCE·Filed 2007·Granted Aug 26, 2008·11 cites·12 claims
- 4388US6821513B1Method for enhancing hematopoiesisUNIV OREGON HEALTH & SCIENCE·Filed 2000·Granted Nov 23, 2004·26 cites·16 claims
- 4487US11578032B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Feb 14, 2023·3 cites·24 claims
- 4587US10760097B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Sep 1, 2020·4 cites·18 claims
- 4687US9040233B2Methods for detecting a Mycobacterium tuberculosis infectionUNIV OREGON HEALTH & SCIENCE·Filed 2012·Granted May 26, 2015·4 cites·19 claims
- 4787US7326534B2Detection of gleevec resistant mutationsUNIV OREGON HEALTH & SCIENCE·Filed 2006·Granted Feb 5, 2008·10 cites·14 claims
- 4887US6602707B2Mammalian cell surface DNA receptor-encoding nucleic acidUNIV OREGON HEALTH & SCIENCE·Filed 2001·Granted Aug 5, 2003·24 cites·19 claims
- 4987US6521608B1Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disordersUNIV OREGON HEALTH & SCIENCE·Filed 1999·Granted Feb 18, 2003·117 cites·54 claims
- 5086US11104654B2Derivatives of sobetiromeUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Aug 31, 2021·5 cites·11 claims
Showing the top 50 of 463 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UNIV OREGON HEALTH & SCIENCE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →